Close
Newsletter
Subscribe to our newsletter
Picture of Assessment and Treatment of Sarcopenia and Frailty in the Setting of Personalized Internal Medicine

Assessment and Treatment of Sarcopenia and Frailty in the Setting of Personalized Internal Medicine

Author(s): Gad Segal

Book Description

The recognition and implementation of personalized internal medicine is of the utmost importance for physicians, nurses, dieticians and other healthcare professionals engaged in clinics. The assessment of sarcopenia and frailty, in middle-aged patients, as an embodiment of treatment personalization, is essential in settings of acute and chronic disease, both in the hospital and in ambulatory settings. This book describes various practical tools for the assessment of sarcopenia and frailty, reviews relevant findings from the current professional literature, and suggests treatment modifications for frail patients.

Hardback

ISBN-13: 978-1-5275-4253-2
ISBN-10: 1-5275-4253-X
Date of Publication: 01/01/2020
Pages / Size: 150 / A5
Price: £58.99
:

Biography

Gad Segal, MD, is Head of Department of Internal Medicine “I” at the Chaim Sheba Medical Centre and a Senior Lecturer at the Sackler Faculty of Medicine at Tel-Aviv University, Israel. He serves on the Supreme Helsinki Committee of the Israeli Ministry of Health and as Secretary of the Israeli Society of Internal Medicine. His main research field is personalized internal medicine, sarcopenia and frailty assessment in internal medicine.

Amir Tirosh, MD, received his MD and PhD from the Faculty of Health Sciences at Ben Gurion University, Israel. He completed his residency in Internal Medicine at Sheba Medical Center, Israel, and his fellowship in Endocrinology and Diabetes at Brigham and Women’s Hospital in Boston, MA. He is an Associate Professor of Medicine at Sackler School of Medicine of Tel-Aviv University and the Chair of the Division of Endocrinology, Diabetes and Metabolism at Sheba Medical Center. H

Idan Goren, MD, is a Researcher at the Division of Gastroenterology at the Rabin Medical Center, Israel. He is involved in numerous clinical and translational research projects in the field of inflammatory bowel disease. His main research interest is the prediction of clinical outcomes at early disease stages, and the interaction between microbial, immune, and nutritional factors associated with intestinal inflammation.

Yishay Wasserstrum, MD, is a Researcher in the Internal Medicine Department “T” and the Leviev Heart Institute at Chaim Sheba Medical Center, Israel. He received his MD from Sackler School of Medicine at Tel-Aviv University, Israel.

Tali Cukierman-Yaffe, MD, is an endocrinologist and clinical epidemiologist. She is a Senior Physician in the Endocrinology Institute and founder and Head of the Centre for Successful Aging with Diabetes at the Sheba Medical Centre, Israel. She holds a research position in the Gertner Institute for Epidemiology and Health Policy Research, Israel, and is a Senior Lecturer in the Epidemiology Department at Tel-Aviv University, Israel.

Liana Tripto-Shkolnik, MD, received her M.Med.Sc in Physiology and her MD from the Joyce and Irvin Goldman School of Medicine at the Faculty of Health Sciences at Ben Gurion University of the Negev, Israel, in 1999. She is currently the Vice-chair of the Division of Endocrinology, Diabetes and Metabolism at Sheba Medical Center, Israel.

Michal Azmon is a Senior Faculty Member in the Physiotherapy Department at Ariel University, Israel. She was previously the CEO of the Israeli Physiotherapy Society, and has extensive experience in physical activity education for older people.

Gad Shlomai, MD, graduated from the Hebrew University and Hadassah Medical School in Jerusalem. He completed his Internal Medicine residency at the Chaim Sheba Medical Center, Israel, and his Endocrinology, Diabetes and Metabolism fellowship at the Icahn School of Medicine, USA. His clinical and research focus is adrenal gland pathologies.